Drag a card by its title · ⚙ to size, swap or remove

The company

REGENXBIO Inc.

RGNX · Nasdaq

Health CareBiotechnologyNot moving yet

RGNX stood above a rising 150-day average in 14 of the last 52 weekly readings, and has been out of that trend for the last 38 weeks. It is 20.6% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 38
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $1.9M
Insider sales, 12 months: $1.9M
Officials’ trades on record: 2
Institutions holding: 155 (-10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 14 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 2, Senate 0, executive 0; 1 people.

Who	Did	Amount	Traded
Peter Welch House: U.S. House ClerkVT00	sold	$1k–$15k	8 Nov 2019filed 14 Nov 2019
Peter Welch House: U.S. House ClerkVT00	bought	$1k–$15k	22 Oct 2019filed 14 Nov 2019

Insiders

Buy orders, 12 months2

Sale orders, 12 months5

Buyers · sellers1 · 1

Who	Did	Shares	Traded
Gregory Austin CiongoliDirector	bought	53,407at $9.36	27 Aug 2026filed 27 Aug 2026
Gregory Austin CiongoliDirector	bought	49,196at $9.14	26 Aug 2026filed 27 Aug 2026
Steve PakolaChief Medical Officer	sold	2,161at $13.64	2 Jul 2026filed 6 Jul 2026
Steve PakolaChief Medical Officer	sold	36,725at $12.86	1 Jul 2026filed 1 Jul 2026
Steve PakolaChief Medical Officer	sold	19,608at $11.04	29 Jun 2026filed 1 Jul 2026
Steve PakolaChief Medical Officer	sold	15,309at $11.02	11 May 2026filed 13 May 2026
Steve PakolaChief Medical Officer	sold	5,124at $10.35	10 Mar 2026filed 12 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders155-10 on the quarter

New · exited25 · 36

Reported value$506.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	6,397,440$76.6M	+614,632+10.6%
Redmile Group, LLCunchanged · filed 14 Aug 2026	4,368,804$52.3M	00.0%
STATE STREET CORPadded · filed 7 Aug 2026	2,971,173$35.6M	+239,688+8.8%
JPMORGAN CHASE & COnew · filed 12 Aug 2026	2,214,169$26.2M	+2,214,169
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,107,557$25.2M	+100,411+5.0%
MORGAN STANLEYreduced · filed 13 Aug 2026	1,953,237$23.4M	-112,920−5.5%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026	1,421,453$17.0M	-418,010−22.7%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026	1,378,358$16.5M	+326,646+31.1%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	1,355,554$16.2M	+336,653+33.0%
MARSHALL WACE, LLPnew · filed 13 Aug 2026	1,284,950$15.4M	+1,284,950